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Abstract
If the outcomes of the recent COAG meeting are implemented, Australia will have a new set of
benchmarks for its health system within a few months. This is a non-trivial task. Choice of
benchmarks will, explicitly or implicitly, reflect a framework about how the health system works,
what is important or to be valued and how the benchmarks are to be used. In this article we argue
that the health system is dynamic and so benchmarks need to measure flows and interfaces rather
than simply cross-sectional or static performance. We also argue that benchmarks need to be
developed taking into account three perspectives: patient, clinician and funder. Each of these
perspectives is critical and good performance from one perspective or on one dimension doesn't
imply good performance on either (or both) of the others.
The three perspectives (we term the dimensions patient assessed value, performance on clinical
interventions and efficiency) can each be decomposed into a number of elements. For example,
patient assessed value is influenced by timeliness, cost to the patient, the extent to which their
expectations are met, the way they are treated and the extent to which there is continuity of care.
We also argue that the way information is presented is important: cross sectional, dated measures
provide much less information and are much less useful than approaches based on statistical
process control. The latter also focuses attention on improvement and trends, encouraging action
rather than simply blame of poorer performers.
Background
The Council of Australian Governments (COAG) commu-
niqué issued after its 20 December 2007 meeting pro-
vided a serious challenge for the yet to be established
National Health and Hospitals Reform Commission
(NHHRC) in specifying terms of reference which included
a requirement that:
by April 2008, the Commission will provide advice on
the framework for the next Australian Health Care
Agreements (AHCAs), including robust performance
benchmarks in areas such as (but not restricted to)
elective surgery, aged and transition care, and quality
of health care.
At the same meeting COAG established a Working Group
on Health and Ageing as a Commonwealth-state officer
level group that to some extent parallels both the role and
timelines of the Commission. The Working Group's indic-
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ative forward work plan for 2008, as endorsed by COAG,
includes:
Consideration of a Commonwealth/State agreement
across the full range of health and wellbeing issues,
including outcomes, measures of progress and
accountability arrangements.
Developing performance measures for the health sector is
complex; getting them agreed between Commonwealth
and states when a considerable amount of funding is at
risk will be an even greater challenge. Developing a per-
formance measurement or benchmarking framework
includes a number of steps. The first step for the NHHRC
is a framework for the AHCAs. Performance measures
within that framework then need to be developed and
agreed.
Frameworks for accountability
There are a number of choices about frameworks for the
health system. As Simon [1] and Lindblom [2] have
pointed out, humans usually exhibit "bounded rational-
ity" when making decisions or planning, where they can-
not consider all aspects of a problem and so limit their
consideration to those aspects which are familiar. This is a
hazard wherever the subdivisions of specialisation are
needed to manage an increasingly complex production
environment, well exemplified by healthcare. Compart-
mentalisation and the "mind maps" of a system shape the
choices decision makers are prepared to consider and thus
the relative emphasis of policy initiatives.
The first task of developing a framework and consequen-
tial performance measures is thus to determine what our
mind map of the health system will be, that is how to
define and describe the health care system. Conventional
approaches to this task are typically influenced by the his-
tory and constraints of analytical approaches and by the
current characteristics of the system. In the former case
Weaver [3] for instance identified three approaches: clas-
sical two variable problems at the least complex end of the
problem spectrum and statistical mechanics at the other
where thousands of variables interact in disorganised
complexity, with a mid zone of organised complexity
where a medium numbers of variables interact. Unfortu-
nately it is in this mid zone, the least well understood or
analytically developed, that most important healthcare
problems reside and where new approaches are needed.
In the latter case, we most commonly describe the system
in institutional terms such as primary care, secondary or
acute care and long term care. This institutional approach
was challenged by COAG decisions under the Hawke/
Keating Government, which attempted to shift the frame
used in health system design from an institutional/pro-
vider oriented one to one more focussed on "meeting peo-
ple's needs" [4]. In contrast to the institutional approach,
the COAG approach identified three different sorts of
needs: primary/episodic needs, chronic or 'coordinated
care' needs, and acute care needs, all of which were situ-
ated within a population health framework.
The critical difference between the institutional and the
population approaches is the identification of needs for
care co-ordination, with the then Labor Government's
response being to sponsor the coordinated care trials [5].
This frame has subsequently fallen into disuse as the insti-
tutional frame of primary or secondary care regained
ascendancy. Insofar as the Howard Government
responded to these chronic disease or coordinated care
needs, policies were developed within an institutional
framework; the main Howard Government response to
this different class of needs was the Enhanced Primary
Care package. Enhanced Primary Care, although an
advance on the pre-existing primary care episodic funding
model, did little to establish new approaches to deal with
the very different needs that were beginning to be recog-
nised with the ageing of the population and changing
health status. If the population focus had continued, Aus-
tralia's health care system could now be very differently
positioned to respond to the growth in chronic disease.
The argument here is not to adopt the old COAG frame-
work of the early to mid 90s, but rather to illustrate that
the choices about how we describe the health system can
influence the emphasis of policy. Those choices about the
framework of the system are thus going to be critical to the
new NHHRC and the officer-level working group.
A second choice that is implicitly made in decisions about
descriptions and measures of the health care system is
whether to emphasise cross-sectional descriptions and
static performance of systems, such as the number of
patients treated or beds open, or de-emphasise these and
emphasise measures of the dynamics of the system. Static
measures predominate, as if the body were to be described
only by its anatomy and not its physiology. A systems
dynamic approach emphasises the stocks and flows of a
system and the reality that the stocks are affected by the
flows and both have to be modelled, designed and meas-
ured [6]. This approach is critical in the health system with
its intricate interdependencies but unfortunately it has
been shown that high intelligence and educational status
are no guarantee that even simple stock and flow prob-
lems can be solved or even understood [7]. What is impor-
tant to take from this then is that any systems of
performance measures needs to focus not only on the
institutions or single components of services but on the
interactions between them.
Benchmarking (and performance measurement gener-
ally) is about evaluation and 'valuing'. This requires aAustralia and New Zealand Health Policy 2008, 5:1 http://www.anzhealthpolicy.com/content/5/1/1
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third choice about what 'value' attributes will be high-
lighted in the design of the performance system. This is as
critical as the choice of the health system framework.
The health care system is characterised by multiple prod-
ucts (acute care, research, teaching) with the 'value' of
each of those products being characterised along multiple
dimensions. In the case of acute care, for example, value
can be measured from the perspective of each of the three
players: the patient, clinicians, and the funder (financial
or technical efficiency perspective). These perspectives
may overlap but often do not, and are sometimes in open
conflict [8,9]. Thus a healthcare facility may perform well
from any one of these perspectives or dimensions and
poorly on either or both of the other two. The 'value' of
the a service should therefore be conceptualised as being
distributed across a "value cube" rather than as a one-
dimensional continuum or a Cartesian plane (see figure
1)
Each dimension of this cube incorporates in turn a
number of distinct elements and thus might itself be
regarded as multi-dimensional. This provides the frame-
work with the additional attraction of scalability: the three
dimensions may be scaled to examine an individual sub-
component or to view the progression from the character-
istics of an individual patient, through aggregation at
clinical service or hospital level up to whole populations.
A patient's journey through the health care system pro-
vides a useful framework for identifying some of the ele-
ments that contribute to patient assessed value and which
might be the subject of performance benchmarks. Kenagy
et al, in a article describing the journey of one of its
authors, use the term 'service quality' for this perspective
on value [9]. Critical elements of patient assessed value
might include:
• A patient's journey involves a number of separate pro-
viders. The quality of this journey is measured in large part
by how effectively the transitions are managed from a
patient perspective i.e. to what extent is there continuity of
care in the transitions including the transition from pri-
mary care to acute care (and back again), from acute care
to any necessary long stay care and so on. The focus
should be on the patient's experience e.g. to what extent is
the patient asked to repeat information at different stages
of the journey? To what extent are diagnostic tests
repeated by different providers? To what extent does a
patient stay in an acute hospital facility inappropriately
prior to relocating to a residential aged care facility?
• Patient perceptions are also affected by the timeliness of
access and this is typically measured in terms of waiting
times. The policy focus has been on waiting times for elec-
tive surgery, but waiting times for the whole journey are
important. In Sweden for example a benchmark described
as 0-7-90-90 has been promulgated, based on a zero wait
for access to a call centre, no longer than a 7 day wait to
be seen for a primary care consultation, no longer than a
90 day wait for a secondary care consultation and no
longer than 90 day wait for treatment to be commenced,
including any necessary hospital admission [10,11]. If
this benchmark were adopted in Australia, the secondary
care wait time would apply to both consultations in a spe-
cialist's private rooms as well as in hospital outpatient
departments. The English National Health Service has
adopted a more ambitious, integrated target: 18 weeks
from first referral to treatment [12].
• Patients commence their journey because of the need for
symptom relief and/or functional improvement and thus
a critical component in assessing value from a patient's
perspective is the extent to which the patient's expectations
of improvement have been met. In Australia we rarely sys-
tematically measure patient's expectations or whether
they are realised. Significant work has been undertaken in
the United Kingdom in terms of 'patient reported out-
come measures' [13]. A significant measurement task
would be required to develop and implement appropriate
measures if Australian benchmarks about responding to
patient symptomatic and functional improvement expec-
tations were to be adopted. We would need to reach an
agreement on the measures, introduce them and develop
reasonable standards for what can be achieved in terms of
improvement of symptom relief and functional improve-
ment. Consideration would need to be given as to
whether generic measures (which would apply across all
specialties) or condition-specific measures are better for
this purpose.
The health care evaluation 'value cube' Figure 1
The health care evaluation 'value cube'.Australia and New Zealand Health Policy 2008, 5:1 http://www.anzhealthpolicy.com/content/5/1/1
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Patients expect health care to improve their condition,
not worsen it. Low mortality, morbidity and risk of
adverse events are obviously critical aspects of patient
expectations and could thus be included in this
dimension. But measurement and identification of
whether a facility is truly different on these indicators
is complex and still a developing science (see discus-
sion below).
• A third facet relates to the patient experience, in particular,
the way a patient is treated during the course of their care,
what Murray and Frenk refer to as 'respect for persons'
[14]. This would include measures such as being treated
with dignity, respect for autonomy and confidentiality,
adequacy of the information provided to them (on admis-
sion, during the course of treatment, at discharge), and so
on.
• Finally a fifth measure is the cost to the patient (costs to
society are the focus of the third dimension of the value
cube). To what extent were there out of pocket costs
involved in accessing treatment? These costs include not
only payments to health service providers but also any
accessibility costs such as costs of travelling and accom-
modation to obtain patient care.
Zeithaml et al have developed a comprehensive list of
generic dimensions of a 'customer' view of service quality
that could be used to flesh out other components of
patient assessed value [15] but the measures proposed
here include measures of flow or co-ordination (first two
dot points above), outcome (third dot point) and proc-
esses of care (last two points).
Clinician defined indicators are usually condition-spe-
cific, so those markers for representative conditions
should be included preferably, and perhaps only, if they
define evidence based best practice interventions for that
condition (e.g. whether appropriate diagnostic tests have
been performed and/or whether appropriate drugs have
been prescribed). As a more stringent test the proportion
of all proven evidence based best practice interventions
for the relevant condition that have been implemented
should ideally be included [16].
Given the link between clinical teamwork and outcomes
[17,18], another process measure of clinical quality might
be a measure of teamwork and communication. The
increasing importance of chronic disease suggests that
benchmarks should also be developed to focus on system
performance in this area, including the extent to which
the health system/facility/provider facilitates patient self-
management. Here dynamic measures might be most
important: higher rates of admissions to hospitals for
avoidable conditions might be regarded as system failures
and poor clinical quality in primary care.
Outcome measures of clinical quality, such as complica-
tions, readmission or mortality rates, could also be con-
sidered as part of a measurement and benchmarking
regime. However, the relative place of outcome versus
process measures of clinical quality is subject to some
debate [19-22]. Process measures have the advantage of
being clearly and unambiguously the responsibility of the
clinician(s) and there is a clear action path from deficits in
process measures to process improvement. Good per-
formance on process markers seems to be associated with
even better than expected performance on outcome meas-
ures, suggesting process measures serve as markers for
other, unmeasured aspects of care [23]. There is certainly
ample scope for improvement in terms of processes as, if
Australian experience replicates that of the United States
in terms clinical practice, on average only about half
(range 10–80%) of those with a valid indication receive
appropriate evidence based therapies or interventions
[24].
Use of outcome measures is more complex from both a
statistical and management perspective. Outcome meas-
ures require greater levels of statistical sophistication to
perform appropriate risk adjustment and identify how
much of any variation is due to chance. Brennan et al put
the argument strongly:
This notion (of individual accidental death) oversim-
plifies the causal realities of iatrogenic injuries, over-
promises on achievable gains, and threatens to skew
priorities in quality-improvement initiatives. Moving
away from a focus on saving lives solely by preventing
errors and instead emphasizing the implementation
of evidence-based practices to improve the quality of
care more generally will yield better long-term results
[19].
Porter and Teisberg have argued for value to be restored to
healthcare through competition based on outcomes
rather than processes of care [25], this is understandable
but as discussed above process markers are more practica-
ble and, if evidence based, process improvement should
lead to gains in outcomes. In a sense, outcome measures
can only flag a difference for further investigation: to what
extent is any difference identified due to coding error,
unadjusted case mix or indeed process variation [26]?
Simply publishing that hospital A has a worse outcome
than hospital B does nothing to improve quality of care.
What is important is that hospital A investigates the rea-
son for variation and addresses any causes within its con-
trol [27]. This might then transform an outcome measureAustralia and New Zealand Health Policy 2008, 5:1 http://www.anzhealthpolicy.com/content/5/1/1
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to a process one: to what extent is any identified variation
addressed in a timely way?
The final dimension of value is one relating to efficiency.
From an economic perspective, efficiency has three key
elements: technical efficiency which broadly speaking can
be defined as efficiency in production (operationalised
normally as inputs divided by outputs e.g. cost per patient
treated) and is represented on the third dimension of the
value cube, allocative efficiency (which may be defined as
ensuring that there is an optimum allocation of resources
in the sense that the marginal dollar spent on any pro-
gram yields the same level of marginal benefit as the last
dollar spent in any other program and thus involves a
focus on outcomes, such as quality adjusted life years
gained relative to inputs) and dynamic efficiency.
Technical efficiency is the easiest to measure of the three
elements and, with total expenditure (which is not a criti-
cal element from an economic perspective as what is rele-
vant is whether there are returns from expenditure, not the
absolute amount spent), tends to be the main foci of 'eco-
nomic' considerations. Importantly, technical efficiency
and clinical performance, although arrayed on different
dimensions, are not inherently antithetical as high clinical
quality can be associated with lower, more appropriate,
use of inputs by, for example, eliminating duplicate diag-
nostic tests [28].
A simple decomposition shows that allocative efficiency
incorporates technical efficiency and moves beyond it to
incorporate a focus on effectiveness, being the outcomes
achieved for each unit of output:
INPUT/OUTCOME (Allocative efficiency) = INPUT/
OUTPUT (Technical efficiency)* OUTPUT/OUTCOME 
(Effectiveness measured as inverse)
Allocative efficiency creates a link with both patient
assessed value and clinical quality, as outcomes can be
measured from either perspective (or both). Allocative
efficiency is thus achieved when both quality and techni-
cal efficiency are optimised (the best outcome for each
output, patient treated).
An economic perspective also involves a focus on dynamic
efficiency, which looks to development and innovation of
new products and processes to improve technical and
allocative efficiency over time. One measure of this might
be investment in, or outputs from, clinical and health
services research and development. So, just as the patient
and clinical perspectives of value incorporate a number of
distinct elements, an economic perspective incorporates
different aspects of efficiency, all of which should be
measured.
These final two elements of efficiency are integrative in
that achievement of allocative or dynamic efficiency
requires performance on multiple axes. In a sense a focus
on allocative and/or dynamic efficiency entails wider soci-
etal perspectives, such as the perspective of the taxpayer or
'the community'. It also provides a link to consideration
of population health issues (discussed below) in the con-
text of the tradeoffs between investments in curative ver-
sus preventive interventions.
The value cube does not incorporate a separate dimension
for equity even though measures of both patient assessed
value and clinician quality of practise could reveal differ-
ent results in different populations. An acute care facility,
for example, could be excellent in terms of patient
assessed value for the majority of its patients, but poor for
distinct sub groups of the population characterised in
terms of race, gender, geography and so on. Similarly,
clinical outcomes of care for different sub groups of the
population may be different. Equity then is not treated in
this model as a separate dimension of the main axes but
rather needs to be considered as part of the distributional
properties of each of the two relevant axes.
The fourth issue that needs to be addressed are the
attributes of the indicators themselves. The management
literature sums up desirable attributes of an indicator with
the acronym SMART. Although the acronym is widely
used, there is some disagreement as to what the constitu-
ent initials stand for. There is agreement that indicators
need to be Specific and Measurable. The A usually stands
for Achievable, (sometimes the lexically similar, Attaina-
ble). The A may also refer to Agreed, Appropriate, Action-
oriented. Young et al have added Aware to this list [29].
The R can stand for Relevant but may also be Realistic (if
A is not Achievable), Rewarding or Results-oriented. T is
Timely (sometimes Time-bound/Time-based or Tactical).
Unfortunately all are desirable properties of indicators,
but rarely are they adequately considered in design of
indicators and benchmarks.
The importance of statistical process control
Whatever measurements are selected in whatever dimen-
sion, it is essential that the most appropriate and effective
methods are used to monitor trends and to demonstrate
any significant positive and negative changes. Such
changes need to be followed at all levels, individual
patient, clinical service, facility or population. As dis-
cussed above biomedical science has been driven by one
legacy of statistical mechanics, the randomised double
blind controlled trial. This is understandable given the
explanatory power of such trials, but in the messy world
of clinical practice they may be of little help – patients
must be treated that would probably have been excludedAustralia and New Zealand Health Policy 2008, 5:1 http://www.anzhealthpolicy.com/content/5/1/1
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in the trial and answers are needed in days or weeks rather
than years.
Fortunately a more appropriate methodology, statistical
process control, is available although relatively neglected
in healthcare until recent times [30]. This may reflect its
humble manufacturing industry origins, but there is
increasing recognition of the value of these techniques in
a wide range of health care activities including the moni-
toring of individual and service safety and quality of care
[24,31-33], acquisition of surgical and procedural skills
[34,35] and patient flow [36]. The particular value of sta-
tistical process control is the rapid access it provides to sig-
nificant trends in local information without the need for
carefully matched control groups. In this context, Pries-
meyer has developed a method of phase plane analysis for
demonstrating changes in two related time series func-
tions that seem useful for tracking both macro-organisa-
tional performance measurements [37] and micro-clinical
aspects such as the expected recovery trajectory after sur-
gery [38]. We believe that this approach can be readily and
usefully extended to the three dimensions as the value
cube.
Measuring the Performance of Population 
Health Activities
The preceding discussion has focused on measuring the
performance of services, but the care system sits within
and is impacted by a wider environment. The health sys-
tem (as distinct from the care system) also incorporates
population health activities, benchmarking these activi-
ties involves somewhat different considerations. In broad
terms the goal of population health programs is to protect
and improve the health status of populations. Achieve-
ment of this goal involves providing direct services to
individuals (e.g. screening services) and provision of pro-
grams with no identifiable individual clients (e.g. food
hygiene regulation).
Population health programs also assume a monitoring or
'tracking' role with respect to the overall health status of
the population. This 'tracking' role usually incorporates
measures of health outcome (morbidity or mortality rates,
incidence and prevalence rates). It is not proposed here to
incorporate them as measures of accountability of the
health system, partly because trends in mortality or mor-
bidity generally cannot be influenced by decision makers
within reasonable time frames and partly because out-
come measures like mortality and morbidity are signifi-
cantly influenced by factors exogenous to the health
system (in this context, probably more accurately called
the health services system). This is not to say that tracking
health outcomes is not useful over the longer term or,
indeed, as part of an evaluation of highly targeted inter-
ventions such as a breast screening program.
Those aspects of population health programs which
involve direct service provision should be evaluated along
the lines of the service dimensions outlined above: the
same issues of patient, clinical and economic perspectives
are just as relevant to population health delivery as they
are to community health or hospital services.
Other than using input or instrumental measures, per-
formance measures for programs where there are no indi-
vidually identifiable clients are somewhat more difficult
to develop. However, output or outcome measures can be
derived from measures of process success or process fail-
ure using hospital or other service databases, such as
admission rates for ambulatory care sensitive conditions
[39-41].
Conclusion
Health services and health systems are complex, generally
involving provision of multiple products. There are also
multiple attributes of the service system that are relevant
to assessing and determining the 'value' of the system.
Together, these characteristics mean that developing a
framework for accountability is exceedingly complex.
Developing a framework for the health care system has to
avoid the same pitfalls involved in specifying objectives so
eloquently described by Nienaber and Wildavsky:
Of objectives it can be said that they invariably may be
distinguished by three outstanding qualities: they are
multiple, conflicting and vague.... The assumption
that objectives are known, clear, and consistent is at
variance with all experience. Objectives are not just
out there, like ripe fruit waiting to be plucked; they are
man-made (sic), artificial, imposed on a recalcitrant
world. Inevitably, they do violence to reality by
emphasising certain activities (and hence organisa-
tional elements) over others. Thus the very process of
defining objectives may be considered a hostile act. It
they are too vague, no evaluation can be done. If they
are too specific, they never encompass all the indefin-
able qualities that their adherents insist they have. If
they are too broad, any activity may be said to contrib-
ute to them. If they are too narrow, they may favour
one segment of the organisation against another [[42],
p10].
So the choice of the framework, measures and associated
benchmarks in the new Australian Health Care Agree-
ments is not a technocratic or value neutral process. It
involves choices on what will be measured, prioritising
some aspects of 'value' over others. In the context of a sys-
tem with responsibilities for different parts of the system
resting with different levels of government, deciding
which areas of the system will be subject to benchmarkingAustralia and New Zealand Health Policy 2008, 5:1 http://www.anzhealthpolicy.com/content/5/1/1
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is a quintessentially political act: what benchmarks will
relate to performance of states and territories and what (if
any) benchmarks will be developed for processes for
which the Commonwealth is accountable?
But the problem will not be solved by allowing every
interest to have its indicator. Too many COAG indicators
will effectively vitiate any accountability process by over-
whelming reviewers with too many data elements. On the
other hand, as Nienaber and Wildavsky point out, too few
indicators will inevitably mean that some important areas
for accountability will be neglected. Consolidating multi-
ple indicators does not solve this issue as assigning
weights associated with each component of the composite
indicator involve the same value or political choices, with
the added risk of loss of transparency [43]. Developing the
right balance of indicators is thus difficult. Balance will
only be achieved however if the particular indicators are
chosen to reflect the particular experiences and aspira-
tions of the key players: the patient, the provider or clini-
cian and the purchaser or funder of services. At the
moment financial/efficiency indicators are most widely
available and precise clinical practice indicators are usu-
ally more widely available but often less precise, and
patient indicators hardly available at all, often poorly
specified, and rarely linked to the other two dimensions.
This balance also needs to be evaluated and displayed
using a framework that makes transparent not only the
interrelationships among these diverse perspectives but
the inevitable compromises that are part of any optimised
health care delivery system. We suggest that the 'value
cube' framework has such potential and the capacity to
graphically represent the global return on investment of
health care funding in a scalable form. In essence this
approach can concisely define and demonstrate value in
healthcare by showing whether clinical intervention(s)
produce the desired patient outcome(s) efficiently and
effectively. This need for this type of analysis will assume
increasing importance with the increasing implementa-
tion of 'pay for performance' funding models [44-49].
So where do we go? The way forward may require more
time than allowed the NHHRC and the Working Group as
there are two tasks which both need to be completed well:
one to develop a framework and appropriate, technically-
sound measures and the other to build acceptance of the
approach. Unfortunately these are not separate and dis-
tinct tasks as participation in design may be necessary for
acceptance. The goal here is widely accepted technically
sound benchmarks, within a short time frame. A formida-
ble task! The compromise may be to develop an interim
list of benchmarks in the short term with a clear agenda,
process, time frame and funding to develop better meas-
ures, benchmarks and reporting approaches over a more
realistic time frame.
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